Two drugs converged in a pancreatic β cell

See allHide authors and affiliations

Science Translational Medicine  12 Feb 2020:
Vol. 12, Issue 530, eaba7359
DOI: 10.1126/scitranslmed.aba7359

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Combining a DYRK1A inhibitor and GLP-1 receptor agonist boosts human pancreatic β cell proliferation and glucose homeostasis in vivo (Ackeifi et al., this issue).

View Full Text

Stay Connected to Science Translational Medicine

Editor's Blog